Glioblastoma multiforme (GBM): An overview of current therapies and mechanisms of resistance
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Glioblastoma multiforme (GBM): An overview of current therapies and mechanisms of resistance
Authors
Keywords
Glioblastoma, Radiotherapy, Chemotherapy, Targeted therapy, Nanotherapy, Immunotherapy
Journal
PHARMACOLOGICAL RESEARCH
Volume 171, Issue -, Pages 105780
Publisher
Elsevier BV
Online
2021-07-22
DOI
10.1016/j.phrs.2021.105780
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeting MCL-1 in hematologic malignancies: Rationale and progress
- (2020) AndrewH. Wei et al. BLOOD REVIEWS
- Rindopepimut with Bevacizumab for Patients with Relapsed EGFRvIII-Expressing Glioblastoma (ReACT): Results of a Double-Blind Randomized Phase II Trial
- (2020) David A. Reardon et al. CLINICAL CANCER RESEARCH
- Clinical implications of intratumor heterogeneity: challenges and opportunities
- (2020) Santiago Ramón y Cajal et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Lipid Peroxidation Plays an Important Role in Chemotherapeutic Effects of Temozolomide and the Development of Therapy Resistance in Human Glioblastoma
- (2020) Wei Wu et al. Translational Oncology
- High Expression of CD44 Predicts a Poor Prognosis in Glioblastomas
- (2020) Daolin Si et al. Cancer Management and Research
- T lymphocyte-targeted immune checkpoint modulation in glioma
- (2020) William James Kelly et al. Journal for ImmunoTherapy of Cancer
- Nano-Therapies for Glioblastoma Treatment
- (2020) Alphandéry Cancers
- O6-Methylguanine-DNA Methyltransferase (MGMT): Challenges and New Opportunities in Glioma Chemotherapy
- (2020) Wei Yu et al. Frontiers in Oncology
- Particle radiation therapy in the management of malignant glioma: Early experience at the Shanghai Proton and Heavy Ion Center
- (2020) Lin Kong et al. CANCER
- MDA-9/Syntenin/SDCBP: new insights into a unique multifunctional scaffold protein
- (2020) Anjan K. Pradhan et al. CANCER AND METASTASIS REVIEWS
- Drug Delivery Systems Using Surface Markers for Targeting Cancer Stem Cells
- (2020) James T. Oswald et al. CURRENT PHARMACEUTICAL DESIGN
- Brain Targeted Gold Liposomes Improve RNAi Delivery for Glioblastoma
- (2020) Nilmary Grafals-Ruiz et al. International Journal of Nanomedicine
- Targeting the ABC transporter ABCB5 sensitizes glioblastoma to temozolomide-induced apoptosis through a cell-cycle checkpoint regulation mechanism
- (2020) Catherine A. A. Lee et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Lessons Learned in Using Laser Interstitial Thermal Therapy for Treatment of Brain Tumors: A Case Series of 238 Patients from a Single Institution
- (2020) Jianning Shao et al. World Neurosurgery
- Effect of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma
- (2020) David A. Reardon et al. JAMA Oncology
- Augmentation of brain tumor interstitial flow via focused ultrasound promotes brain-penetrating nanoparticle dispersion and transfection
- (2020) Colleen T. Curley et al. Science Advances
- Understanding Glioblastoma Biomarkers: Knocking a Mountain with a Hammer
- (2020) Malak Hassn Mesrati et al. Cells
- Next Generation Sequencing and Machine Learning Technologies Are Painting the Epigenetic Portrait of Glioblastoma
- (2020) Ivana Jovčevska Frontiers in Oncology
- PARP inhibitor cyanine dye conjugate with enhanced cytotoxic and antiproliferative activity in patient derived glioblastoma cell lines
- (2020) Peter J. Choi et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Radiation-induced bystander and abscopal effects: important lessons from preclinical models
- (2020) Elisabeth Daguenet et al. BRITISH JOURNAL OF CANCER
- The Role of Liquid Biopsies in Pediatric Brain Tumors
- (2020) Karen Tang et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Targeting the synthetic vulnerability of PTEN-deficient glioblastoma cells with MCL1 inhibitors
- (2020) Chao Chen et al. MOLECULAR CANCER THERAPEUTICS
- Advances and potential pitfalls of oncolytic viruses expressing immunomodulatory transgene therapy for malignant gliomas
- (2020) Qing Zhang et al. Cell Death & Disease
- Longer-term (≥ 2 years) survival in patients with glioblastoma in population-based studies pre- and post-2005: a systematic review and meta-analysis
- (2020) Michael T. C. Poon et al. Scientific Reports
- NF-κB inhibitor with Temozolomide results in significant apoptosis in glioblastoma via the NF-κB(p65) and actin cytoskeleton regulatory pathways
- (2020) Naze G. Avci et al. Scientific Reports
- Machine Learning Based on a Multiparametric and Multiregional Radiomics Signature Predicts Radiotherapeutic Response in Patients with Glioblastoma
- (2020) Zi-Qi Pan et al. BEHAVIOURAL NEUROLOGY
- Oncolytic Virotherapy in Glioma Tumors
- (2020) Sergio Rius-Rocabert et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Engineering Three-Dimensional Tumor Models to Study Glioma Cancer Stem Cells and Tumor Microenvironment
- (2020) Henry Ruiz-Garcia et al. Frontiers in Cellular Neuroscience
- Effects of 5-ALA dose on resection of glioblastoma
- (2019) Alex P. Michael et al. JOURNAL OF NEURO-ONCOLOGY
- 5-ALA and FDA approval for glioma surgery
- (2019) Constantinos G. Hadjipanayis et al. JOURNAL OF NEURO-ONCOLOGY
- Turning “Cold” Into “Hot” Tumors—Opportunities and Challenges for Radio-Immunotherapy Against Primary and Metastatic Brain Cancers
- (2019) Lisa Sevenich Frontiers in Oncology
- Glioblastoma Stem-Like Cells, Metabolic Strategy to Kill a Challenging Target
- (2019) Delphine Garnier et al. Frontiers in Oncology
- Modeling Patient-Derived Glioblastoma with Cerebral Organoids
- (2019) Amanda Linkous et al. Cell Reports
- Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma
- (2019) Timothy F. Cloughesy et al. NATURE MEDICINE
- Longitudinal heterogeneity in glioblastoma: moving targets in recurrent versus primary tumors
- (2019) Niklas Schäfer et al. Journal of Translational Medicine
- The landscape of the mesenchymal signature in brain tumours
- (2019) Jinan Behnan et al. BRAIN
- Polymalic acid chlorotoxin nanoconjugate for near-infrared fluorescence guided resection of glioblastoma multiforme
- (2019) Rameshwar Patil et al. BIOMATERIALS
- Evolution of Magnetic Hyperthermia for Glioblastoma Multiforme Therapy
- (2019) Ruby Gupta et al. ACS Chemical Neuroscience
- Enhancing Boron Uptake in Brain Glioma by a Boron-Polymer/Microbubble Complex with Focused Ultrasound
- (2019) Ching-Hsiang Fan et al. ACS Applied Materials & Interfaces
- Reactive Oxygen Species (ROS)-Based Nanomedicine
- (2019) Bowen Yang et al. CHEMICAL REVIEWS
- Cediranib suppresses homology-directed DNA repair through down-regulation of BRCA1/2 and RAD51
- (2019) Alanna R. Kaplan et al. Science Translational Medicine
- Stem cell-associated heterogeneity in Glioblastoma results from intrinsic tumor plasticity shaped by the microenvironment
- (2019) Anne Dirkse et al. Nature Communications
- Identification of Potential Biomarkers in Glioblastoma through Bioinformatic Analysis and Evaluating Their Prognostic Value
- (2019) Yangmei Zhou et al. Biomed Research International
- Non-viral nano-immunotherapeutics targeting tumor microenvironmental immune cells
- (2019) Seok-Beom Yong et al. BIOMATERIALS
- A phase 1 and randomized, placebo‐controlled phase 2 trial of bevacizumab plus dasatinib in patients with recurrent glioblastoma: Alliance/North Central Cancer Treatment Group N0872
- (2019) Evanthia Galanis et al. CANCER
- Glioblastoma stem cells: lessons from the tumor hierarchy in a lethal cancer
- (2019) Ryan C. Gimple et al. GENES & DEVELOPMENT
- Proneural-Mesenchymal Transition: Phenotypic Plasticity to Acquire Multitherapy Resistance in Glioblastoma
- (2019) Monica Fedele et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- CAR-T cells secreting BiTEs circumvent antigen escape without detectable toxicity
- (2019) Bryan D. Choi et al. NATURE BIOTECHNOLOGY
- Mechanisms of immunotherapy resistance: lessons from glioblastoma
- (2019) Christopher M. Jackson et al. NATURE IMMUNOLOGY
- Radiation therapy and anti-tumor immunity: exposing immunogenic mutations to the immune system
- (2019) Claire Lhuillier et al. Genome Medicine
- B7-H3 as a novel CAR-T therapeutic target for glioblastoma
- (2019) Xin Tang et al. Molecular Therapy-Oncolytics
- C8-Substituted Imidazotetrazine Analogs Overcome Temozolomide Resistance by Inducing DNA Adducts and DNA Damage
- (2019) Zhikuan Yang et al. Frontiers in Oncology
- Survival Outcomes Among Patients With High-Grade Glioma Treated With 5-Aminolevulinic Acid–Guided Surgery: A Systematic Review and Meta-Analysis
- (2019) Sirin Gandhi et al. Frontiers in Oncology
- Enhanced anti-angiogenic effects of bevacizumab in glioblastoma treatment upon intranasal administration in polymeric nanoparticles
- (2019) Flávia Sousa et al. JOURNAL OF CONTROLLED RELEASE
- Open-Label Phase II Evaluation of Imatinib in Primary Inoperable or Incompletely Resected and Recurrent Glioblastoma
- (2019) Lisa Sautter et al. ONCOLOGY
- Molecular targeted therapy of glioblastoma
- (2019) Emilie Le Rhun et al. CANCER TREATMENT REVIEWS
- The current state of immunotherapy for gliomas: an eye toward the future
- (2019) Peter E. Fecci et al. JOURNAL OF NEUROSURGERY
- Role of hypoxia in cancer therapy by regulating the tumor microenvironment
- (2019) Xinming Jing et al. Molecular Cancer
- Romiplostim for temozolomide-induced thrombocytopenia in glioblastoma
- (2019) Emilie Le Rhun et al. NEUROLOGY
- CXCR1- or CXCR2-modified CAR T cells co-opt IL-8 for maximal antitumor efficacy in solid tumors
- (2019) Linchun Jin et al. Nature Communications
- Recent Advances in the Use of Focused Ultrasound for Magnetic Resonance Image-Guided Therapeutic Nanoparticle Delivery to the Central Nervous System
- (2019) Delaney G. Fisher et al. Frontiers in Pharmacology
- Ultrasound-Induced Blood-Brain-Barrier Opening Enhances Anticancer Efficacy in the Treatment of Glioblastoma: Current Status and Future Prospects
- (2019) Zhiting Deng et al. Journal of Oncology
- Wnt-Induced Stabilization of KDM4C Is Required for Wnt/β-Catenin Target Gene Expression and Glioblastoma Tumorigenesis
- (2019) Yaohui Chen et al. CANCER RESEARCH
- EGFR Amplification Induces Increased DNA Damage Response and Renders Selective Sensitivity to Talazoparib (PARP Inhibitor) in Glioblastoma
- (2019) Shaofang Wu et al. CLINICAL CANCER RESEARCH
- Combined treatment of AT101 and demethoxycurcumin yields an enhanced anti-proliferative effect in human primary glioblastoma cells
- (2019) Moiken Mehner et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Tumour Treating Fields in combination with pemetrexed and cisplatin or carboplatin as first-line treatment for unresectable malignant pleural mesothelioma (STELLAR): a multicentre, single-arm phase 2 trial
- (2019) Giovanni L Ceresoli et al. LANCET ONCOLOGY
- First-In-Human Phase I Study Of A Dual mTOR Kinase And DNA-PK Inhibitor (CC-115) In Advanced Malignancy
- (2019) Pamela Munster et al. Cancer Management and Research
- ABC Transporters at the Blood–Brain Interfaces, Their Study Models, and Drug Delivery Implications in Gliomas
- (2019) David Gomez-Zepeda et al. Pharmaceutics
- Functional morphology of the blood–brain barrier in health and disease
- (2018) Stefan Liebner et al. ACTA NEUROPATHOLOGICA
- MicroRNAs as biomarkers for human glioblastoma: progress and potential
- (2018) Shi-wei Huang et al. ACTA PHARMACOLOGICA SINICA
- Tumor targeting via EPR: Strategies to enhance patient responses
- (2018) Susanne K. Golombek et al. ADVANCED DRUG DELIVERY REVIEWS
- Up-regulation of MSH6 is associated with temozolomide resistance in human glioblastoma
- (2018) Quanye Sun et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Phase 1/2 trial of temsirolimus and sorafenib in the treatment of patients with recurrent glioblastoma: North Central Cancer Treatment Group Study/Alliance N0572
- (2018) David Schiff et al. CANCER
- Tumor Evolution of Glioma-Intrinsic Gene Expression Subtypes Associates with Immunological Changes in the Microenvironment
- (2018) Qianghu Wang et al. CANCER CELL
- Aldehyde dehydrogenase 1A3 (ALDH1A3) is regulated by autophagy in human glioblastoma cells
- (2018) Wei Wu et al. CANCER LETTERS
- Inhibition of NF-κB results in anti-glioma activity and reduces temozolomide-induced chemoresistance by down-regulating MGMT gene expression
- (2018) Zhiyun Yu et al. CANCER LETTERS
- Cellular origin of glioblastoma and its implication in precision therapy
- (2018) Maojin Yao et al. Cellular & Molecular Immunology
- Temozolomide loaded nano lipid based chitosan hydrogel for nose to brain delivery: Characterization, nasal absorption, histopathology and cell line study
- (2018) Anam Khan et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Magnetic hyperthermia therapy for the treatment of glioblastoma: a review of the therapy’s history, efficacy and application in humans
- (2018) Keon Mahmoudi et al. INTERNATIONAL JOURNAL OF HYPERTHERMIA
- Mechanisms of enhanced antiglioma efficacy of polysorbate 80-modified paclitaxel-loaded PLGA nanoparticles by focused ultrasound
- (2018) Yingjia Li et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Phase I Study of DNX-2401 (Delta-24-RGD) Oncolytic Adenovirus: Replication and Immunotherapeutic Effects in Recurrent Malignant Glioma
- (2018) Frederick F. Lang et al. JOURNAL OF CLINICAL ONCOLOGY
- Dendritic Cell–Based Cancer Vaccines
- (2018) Patricia M. Santos et al. JOURNAL OF IMMUNOLOGY
- First-in-human intraoperative near-infrared fluorescence imaging of glioblastoma using cetuximab-IRDye800
- (2018) Sarah E. Miller et al. JOURNAL OF NEURO-ONCOLOGY
- Repair gene O6 -methylguanine-DNA methyltransferase is controlled by SP1 and up-regulated by glucocorticoids, but not by temozolomide and radiation
- (2018) Dorthe Aasland et al. JOURNAL OF NEUROCHEMISTRY
- Laser ablation after stereotactic radiosurgery: a multicenter prospective study in patients with metastatic brain tumors and radiation necrosis
- (2018) Manmeet Ahluwalia et al. JOURNAL OF NEUROSURGERY
- Constitutive Interferon Pathway Activation in Tumors as an Efficacy Determinant Following Oncolytic Virotherapy
- (2018) Cheyne Kurokawa et al. JNCI-Journal of the National Cancer Institute
- First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma
- (2018) Linda M. Liau et al. Journal of Translational Medicine
- Convection-enhanced delivery for diffuse intrinsic pontine glioma: a single-centre, dose-escalation, phase 1 trial
- (2018) Mark M Souweidane et al. LANCET ONCOLOGY
- Bioreducible Polymeric Nanoparticles Containing Multiplexed Cancer Stem Cell Regulating miRNAs Inhibit Glioblastoma Growth and Prolong Survival
- (2018) Hernando Lopez-Bertoni et al. NANO LETTERS
- Current state of immunotherapy for glioblastoma
- (2018) Michael Lim et al. Nature Reviews Clinical Oncology
- Phase 1 trial, pharmacokinetics, and pharmacodynamics of dasatinib combined with crizotinib in children with recurrent or progressive high-grade and diffuse intrinsic pontine glioma
- (2018) Alberto Broniscer et al. PEDIATRIC BLOOD & CANCER
- MDA-9/Syntenin regulates protective autophagy in anoikis-resistant glioma stem cells
- (2018) Sarmistha Talukdar et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Progress and challenges towards targeted delivery of cancer therapeutics
- (2018) Daniel Rosenblum et al. Nature Communications
- Dendritic cell activation enhances anti-PD-1 mediated immunotherapy against glioblastoma
- (2018) Tomas Garzon-Muvdi et al. Oncotarget
- Concordant association validates MGMT methylation and protein expression as favorable prognostic factors in glioma patients on alkylating chemotherapy (Temozolomide)
- (2018) Arshad A. Pandith et al. Scientific Reports
- Radiosensitization Effect of Talazoparib, a Parp Inhibitor, on Glioblastoma Stem Cells Exposed to Low and High Linear Energy Transfer Radiation
- (2018) Paul Lesueur et al. Scientific Reports
- In vivo delineation of glioblastoma by targeting tumor-associated macrophages with near-infrared fluorescent silica coated iron oxide nanoparticles in orthotopic xenografts for surgical guidance
- (2018) Chaedong Lee et al. Scientific Reports
- Real-Time Imaging of Brain Tumor for Image-Guided Surgery
- (2018) Shuang Hu et al. Advanced Healthcare Materials
- Constitutive Interferon Pathway Activation in Tumors as an Efficacy Determinant Following Oncolytic Virotherapy
- (2018) Cheyne Kurokawa et al. JNCI-Journal of the National Cancer Institute
- Temozolomide and Pituitary Tumors: Current Understanding, Unresolved Issues, and Future Directions
- (2018) Luis V. Syro et al. Frontiers in Endocrinology
- Anti-PD-1 and Anti-CTLA-4 Therapies in Cancer: Mechanisms of Action, Efficacy, and Limitations
- (2018) Judith A. Seidel et al. Frontiers in Oncology
- Hypoxia-Inducible Factor-1α Activity as a Switch for Glioblastoma Responsiveness to Temozolomide
- (2018) Alessia Lo Dico et al. Frontiers in Oncology
- Modulating Hypoxia via Nanomaterials Chemistry for Efficient Treatment of Solid Tumors
- (2018) Yanyan Liu et al. ACCOUNTS OF CHEMICAL RESEARCH
- Regulation of protective autophagy in anoikis-resistant glioma stem cells by SDCBP/MDA-9/Syntenin
- (2018) Sarmistha Talukdar et al. Autophagy
- Immunohistochemical Assessment of MGMT Expression and p53 Mutation in Glioblastoma Multiforme
- (2018) Marziyeh Lotfi et al. TUMORI
- Inhibition of autophagy increases susceptibility of glioblastoma stem cells to temozolomide by igniting ferroptosis
- (2018) Mariachiara Buccarelli et al. Cell Death & Disease
- Nano based drug delivery systems: recent developments and future prospects
- (2018) Jayanta Kumar Patra et al. JOURNAL OF NANOBIOTECHNOLOGY
- Temozolomide Induces Senescence and Repression of DNA Repair Pathways in Glioblastoma Cells via Activation of ATR–CHK1, p21, and NF-κB
- (2018) Dorthe Aasland et al. CANCER RESEARCH
- Clinical Significance of Extracellular Vesicles in Plasma from Glioblastoma Patients
- (2018) Daniela Osti et al. CLINICAL CANCER RESEARCH
- Targeting mTOR in Glioblastoma: Rationale and Preclinical/Clinical Evidence
- (2018) Carmen Mecca et al. DISEASE MARKERS
- Cell Cycle Changes after Glioblastoma Stem Cell Irradiation: The Major Role of RAD51
- (2018) Gaelle Tachon et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Functional Biological Activity of Sorafenib as a Tumor-Treating Field Sensitizer for Glioblastoma Therapy
- (2018) Yunhui Jo et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Phase 2 Study of Radiation Therapy Plus Low Dose Temozolomide Followed by Temozolomide and Irinotecan for Glioblastoma: NRG Oncology RTOG Trial 0420
- (2018) Frank S. Lieberman et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Cerebrospinal fluid-suppressed T2 -weighted MR imaging at 7 T for human brain
- (2018) Jullie W. Pan et al. MAGNETIC RESONANCE IN MEDICINE
- T-cell exhaustion in glioblastoma
- (2018) Karolina Woroniecka et al. Oncotarget
- Combined Fluorescence Using 5-Aminolevulinic Acid and Fluorescein Sodium at Glioblastoma Border: Intraoperative Findings and Histopathologic Data About 3 Newly Diagnosed Consecutive Cases
- (2018) Alessandro Della Puppa et al. World Neurosurgery
- Evaluation of Three Morphologically Distinct Virus-Like Particles as Nanocarriers for Convection-Enhanced Drug Delivery to Glioblastoma
- (2018) Joel Finbloom et al. Nanomaterials
- Recent Advances in Oncolytic Virotherapy and Immunotherapy for Glioblastoma: A Glimmer of Hope in the Search for an Effective Therapy?
- (2018) Aleksei Stepanenko et al. Cancers
- Epigenetic Targeting of Glioblastoma
- (2018) Massimo Romani et al. Frontiers in Oncology
- Angiogenesis inhibitors in tackling recurrent glioblastoma
- (2017) Thomas Hundsberger et al. Expert Review of Anticancer Therapy
- Obstacles to Brain Tumor Therapy: Key ABC Transporters
- (2017) Juwina Wijaya et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Hypoxia-responsive ionizable liposome delivery siRNA for glioma therapy
- (2017) Hong-Mei Liu et al. International Journal of Nanomedicine
- The prognostic value of MGMT promoter methylation in glioblastoma: A meta-analysis of clinical trials
- (2017) Maryam Moradi Binabaj et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Phase I study of sorafenib and tipifarnib for recurrent glioblastoma: NABTC 05-02
- (2017) Phioanh Leia Nghiemphu et al. JOURNAL OF NEURO-ONCOLOGY
- Synergistic inhibition of glioma cell proliferation by Withaferin A and tumor treating fields
- (2017) Edwin Chang et al. JOURNAL OF NEURO-ONCOLOGY
- The role of bevacizumab in the treatment of glioblastoma
- (2017) Roberto Jose Diaz et al. JOURNAL OF NEURO-ONCOLOGY
- The effects of new or worsened postoperative neurological deficits on survival of patients with glioblastoma
- (2017) Maryam Rahman et al. JOURNAL OF NEUROSURGERY
- Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial
- (2017) Michael Weller et al. LANCET ONCOLOGY
- Brain shift in neuronavigation of brain tumors: A review
- (2017) Ian J. Gerard et al. MEDICAL IMAGE ANALYSIS
- Multidrug resistance in glioblastoma stem-like cells: Role of the hypoxic microenvironment and adenosine signaling
- (2017) Daniel Uribe et al. MOLECULAR ASPECTS OF MEDICINE
- Epigenetics in cancer stem cells
- (2017) Tan Boon Toh et al. Molecular Cancer
- A Novel Theranostic Strategy for MMP-14 –Expressing Glioblastomas Impacts Survival
- (2017) Suchismita Mohanty et al. MOLECULAR CANCER THERAPEUTICS
- Restricted Delivery of Talazoparib Across the Blood–Brain Barrier Limits the Sensitizing Effects of PARP Inhibition on Temozolomide Therapy in Glioblastoma
- (2017) Sani H. Kizilbash et al. MOLECULAR CANCER THERAPEUTICS
- Current Clinical Brain Tumor Imaging
- (2017) Javier E. Villanueva-Meyer et al. NEUROSURGERY
- DNA methylation and histone modifications as epigenetic regulation in prostate cancer
- (2017) Maria Nowacka-Zawisza et al. ONCOLOGY REPORTS
- A single dose of peripherally infused EGFRvIII-directed CAR T cells mediates antigen loss and induces adaptive resistance in patients with recurrent glioblastoma
- (2017) Donald M. O’Rourke et al. Science Translational Medicine
- Radiation therapy primes tumors for nanotherapeutic delivery via macrophage-mediated vascular bursts
- (2017) Miles A. Miller et al. Science Translational Medicine
- In vivo imaging reveals a tumor-associated macrophage–mediated resistance pathway in anti–PD-1 therapy
- (2017) Sean P. Arlauckas et al. Science Translational Medicine
- MRI-Guided Interstitial Laser Ablation for Intracranial Lesions: A Large Single-Institution Experience of 133 Cases
- (2017) Ashwin A. Kamath et al. STEREOTACTIC AND FUNCTIONAL NEUROSURGERY
- Repair, Reuse, Recycle: The Expanding Role of Autophagy in Genome Maintenance
- (2017) Graeme Hewitt et al. TRENDS IN CELL BIOLOGY
- Methylation regulates HEY1 expression in glioblastoma
- (2017) Andrew J. Tsung et al. Oncotarget
- Multifunctional targeted liposomal drug delivery for efficient glioblastoma treatment
- (2017) Zakia Belhadj et al. Oncotarget
- Epigenetic regulation of NOTCH1 and NOTCH3 by KMT2A inhibits glioma proliferation
- (2017) Yin-Cheng Huang et al. Oncotarget
- Diagnostic and Therapeutic Biomarkers in Glioblastoma: Current Status and Future Perspectives
- (2017) Wojciech Szopa et al. Biomed Research International
- Targeted Nanotechnology in Glioblastoma Multiforme
- (2017) Talita Glaser et al. Frontiers in Pharmacology
- Specificity protein 1-modulated superoxide dismutase 2 enhances temozolomide resistance in glioblastoma, which is independent of O 6 -methylguanine-DNA methyltransferase
- (2017) Kwang-Yu Chang et al. Redox Biology
- Is the prognostic significance of O6-methylguanine-DNA methyltransferase promoter methylation equally important in glioblastomas of patients from different continents? A systematic review with meta-analysis
- (2017) Wei Meng et al. Cancer Management and Research
- HER2-Specific Chimeric Antigen Receptor–Modified Virus-Specific T Cells for Progressive Glioblastoma
- (2017) Nabil Ahmed et al. JAMA Oncology
- The Role of Hypoxia in Glioblastoma Invasion
- (2017) Ana Monteiro et al. Cells
- Sensitization of glioblastoma tumor micro-environment to chemo- and immunotherapy by Galectin-1 intranasal knock-down strategy
- (2017) Matthias Van Woensel et al. Scientific Reports
- The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
- (2016) David N. Louis et al. ACTA NEUROPATHOLOGICA
- Nanovesicle-mediated systemic delivery of microRNA-34a for CD44 overexpressing gastric cancer stem cell therapy
- (2016) Eunji Jang et al. BIOMATERIALS
- Glioblastoma: exosome and microRNA as novel diagnosis biomarkers
- (2016) L Saadatpour et al. CANCER GENE THERAPY
- Phase II Study of Radiotherapy and Temsirolimus versus Radiochemotherapy with Temozolomide in Patients with Newly Diagnosed Glioblastoma without MGMT Promoter Hypermethylation (EORTC 26082)
- (2016) W. Wick et al. CLINICAL CANCER RESEARCH
- Combination Therapy with Anti-PD-1, Anti-TIM-3, and Focal Radiation Results in Regression of Murine Gliomas
- (2016) Jennifer E. Kim et al. CLINICAL CANCER RESEARCH
- Re-Examining the Need for Tissue Diagnosis in Pediatric Diffuse Intrinsic Pontine Gliomas: A Review
- (2016) Libby Infinger et al. Current Neuropharmacology
- The influence of maximum safe resection of glioblastoma on survival in 1229 patients: Can we do better than gross-total resection?
- (2016) Yan Michael Li et al. JOURNAL OF NEUROSURGERY
- DNA repair mechanisms and their clinical impact in glioblastoma
- (2016) Hélène Erasimus et al. MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH
- High-throughput identification of genotype-specific cancer vulnerabilities in mixtures of barcoded tumor cell lines
- (2016) Channing Yu et al. NATURE BIOTECHNOLOGY
- Iron oxide nanoparticles inhibit tumour growth by inducing pro-inflammatory macrophage polarization in tumour tissues
- (2016) Saeid Zanganeh et al. Nature Nanotechnology
- The role of brachytherapy in the treatment of glioblastoma multiforme
- (2016) Eric Barbarite et al. NEUROSURGICAL REVIEW
- Non-coding RNAs as regulators in epigenetics
- (2016) Jian-Wei Wei et al. ONCOLOGY REPORTS
- Multi-Center Randomized Phase II Study Comparing Cediranib plus Gefitinib with Cediranib plus Placebo in Subjects with Recurrent/Progressive Glioblastoma
- (2016) Nicholas Brown et al. PLoS One
- Inhibition of radiation-induced glioblastoma invasion by genetic and pharmacological targeting of MDA-9/Syntenin
- (2016) Timothy P. Kegelman et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The epigenetic landscape of T cell exhaustion
- (2016) D. R. Sen et al. SCIENCE
- Epigenetic stability of exhausted T cells limits durability of reinvigoration by PD-1 blockade
- (2016) K. E. Pauken et al. SCIENCE
- Glioblastoma, hypoxia and autophagy: a survival-prone ‘ménage-à-trois’
- (2016) Soha Jawhari et al. Cell Death & Disease
- Glioblastoma multiforme: Effect of hypoxia and hypoxia inducible factors on therapeutic approaches
- (2016) Wen-Juan Huang et al. Oncology Letters
- Evolution of Neoantigen Landscape during Immune Checkpoint Blockade in Non–Small Cell Lung Cancer
- (2016) Valsamo Anagnostou et al. Cancer Discovery
- Multi-platform molecular profiling of a large cohort of glioblastomas reveals potential therapeutic strategies
- (2016) Joanne Xiu et al. Oncotarget
- The clinical value of aberrant epigenetic changes of DNA damage repair genes in human cancer
- (2016) Dan Gao et al. Oncotarget
- Glioma Stem Cells and Their Microenvironments: Providers of Challenging Therapeutic Targets
- (2016) Elena Codrici et al. Stem Cells International
- Glioblastoma Stem Cells Microenvironment: The Paracrine Roles of the Niche in Drug and Radioresistance
- (2016) Alessia Fidoamore et al. Stem Cells International
- Heavy Ions in Cancer Therapy
- (2016) Arnold Pompos et al. JAMA Oncology
- Editorial: Tumor Hypoxia: Impact in Tumorigenesis, Diagnosis, Prognosis, and Therapeutics
- (2016) Christian R. Gomez Frontiers in Oncology
- Selective Inhibition of Parallel DNA Damage Response Pathways Optimizes Radiosensitization of Glioblastoma Stem-like Cells
- (2015) S. U. Ahmed et al. CANCER RESEARCH
- Minor Changes in Expression of the Mismatch Repair Protein MSH2 Exert a Major Impact on Glioblastoma Response to Temozolomide
- (2015) J. L. McFaline-Figueroa et al. CANCER RESEARCH
- New insights into the mechanism of DNA mismatch repair
- (2015) Gloria X. Reyes et al. CHROMOSOMA
- Image-guided surgery
- (2015) Dan E. Azagury et al. CURRENT PROBLEMS IN SURGERY
- Emerging circulating biomarkers in glioblastoma: promises and challenges
- (2015) Mehdi Touat et al. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
- Regulation of expression of O6-methylguanine-DNA methyltransferase and the treatment of glioblastoma (Review)
- (2015) GIULIO CABRINI et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Maintenance Therapy With Tumor-Treating Fields Plus Temozolomide vs Temozolomide Alone for Glioblastoma
- (2015) Roger Stupp et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Epigenetic Pathways and Glioblastoma Treatment: Insights From Signaling Cascades
- (2015) Bryce K. Allen et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Lessons From Anti–Vascular Endothelial Growth Factor and Anti–Vascular Endothelial Growth Factor Receptor Trials in Patients With Glioblastoma
- (2015) Christine Lu-Emerson et al. JOURNAL OF CLINICAL ONCOLOGY
- Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma
- (2015) Robert H.I. Andtbacka et al. JOURNAL OF CLINICAL ONCOLOGY
- Improving drug delivery to solid tumors: Priming the tumor microenvironment
- (2015) Iftikhar Ali Khawar et al. JOURNAL OF CONTROLLED RELEASE
- New trends for overcoming ABCG2/BCRP-mediated resistance to cancer therapies
- (2015) David Westover et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- A phase II study of bevacizumab and erlotinib after radiation and temozolomide in MGMT unmethylated GBM patients
- (2015) J. J. Raizer et al. JOURNAL OF NEURO-ONCOLOGY
- A randomized phase I/II study of ABT-888 in combination with temozolomide in recurrent temozolomide resistant glioblastoma: an NRG oncology RTOG group study
- (2015) H. Ian Robins et al. JOURNAL OF NEURO-ONCOLOGY
- Study of the biodistribution of fluorescein in glioma-infiltrated mouse brain and histopathological correlation of intraoperative findings in high-grade gliomas resected under fluorescein fluorescence guidance
- (2015) Roberto Jose Diaz et al. JOURNAL OF NEUROSURGERY
- WNT signaling in glioblastoma and therapeutic opportunities
- (2015) Yeri Lee et al. LABORATORY INVESTIGATION
- Efficacy of PARP Inhibitor Rucaparib in Orthotopic Glioblastoma Xenografts Is Limited by Ineffective Drug Penetration into the Central Nervous System
- (2015) K. E. Parrish et al. MOLECULAR CANCER THERAPEUTICS
- Nanoparticle uptake: The phagocyte problem
- (2015) Heather Herd Gustafson et al. Nano Today
- Convection-Enhanced Delivery of Carboplatin PLGA Nanoparticles for the Treatment of Glioblastoma
- (2015) Azeem Arshad et al. PLoS One
- Noninvasive brain cancer imaging with a bispecific antibody fragment, generated via click chemistry
- (2015) Haiming Luo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The future of immune checkpoint therapy
- (2015) P. Sharma et al. SCIENCE
- The Blood–Brain Barrier
- (2015) Richard Daneman et al. Cold Spring Harbor Perspectives in Biology
- Convergence of Acquired Mutations and Alternative Splicing of CD19 Enables Resistance to CART-19 Immunotherapy
- (2015) E. Sotillo et al. Cancer Discovery
- Improved anti-glioblastoma efficacy by IL-13Rα2 mediated copolymer nanoparticles loaded with paclitaxel
- (2015) Baoyan Wang et al. Scientific Reports
- Concise Review: Emerging Role of CD44 in Cancer Stem Cells: A Promising Biomarker and Therapeutic Target
- (2015) Yongmin Yan et al. Stem Cells Translational Medicine
- Progression of Lung Cancer Is Associated with Increased Dysfunction of T Cells Defined by Coexpression of Multiple Inhibitory Receptors
- (2015) D. S. Thommen et al. Cancer Immunology Research
- Inhibition of multidrug resistance protein 1 (MRP1) improves chemotherapy drug response in primary and recurrent glioblastoma multiforme
- (2015) Amanda Tivnan et al. Frontiers in Neuroscience
- Temozolomide Resistance in Glioblastoma Cell Lines: Implication of MGMT, MMR, P-Glycoprotein and CD133 Expression
- (2015) Gloria Perazzoli et al. PLoS One
- Hedgehog signaling sensitizes Glioma stem cells to endogenous nano-irradiation
- (2015) Agnieszka Morgenroth et al. Oncotarget
- The Clinical Importance of Assessing Tumor Hypoxia: Relationship of Tumor Hypoxia to Prognosis and Therapeutic Opportunities
- (2014) Joseph C. Walsh et al. ANTIOXIDANTS & REDOX SIGNALING
- Regulation of histone methylation by noncoding RNAs
- (2014) Richard I. Joh et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- Effects of cytosine methylation on transcription factor binding sites
- (2014) Yulia A Medvedeva et al. BMC GENOMICS
- Erlotinib: early clinical development in brain cancer
- (2014) Raffaele Addeo et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- The Diagnosis and Treatment of Pseudoprogression, Radiation Necrosis and Brain Tumor Recurrence
- (2014) Kashif Parvez et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Histone methyltransferase G9a and H3K9 dimethylation inhibit the self-renewal of glioma cancer stem cells
- (2014) Hong Tao et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- MGMT testing—the challenges for biomarker-based glioma treatment
- (2014) Wolfgang Wick et al. Nature Reviews Neurology
- Expression of DNA mismatch repair proteins MLH1, MSH2, and MSH6 in recurrent glioblastoma
- (2014) Andreas M. Stark et al. NEUROLOGICAL RESEARCH
- Intraoperative mass spectrometry mapping of an onco-metabolite to guide brain tumor surgery
- (2014) S. Santagata et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma
- (2014) A. P. Patel et al. SCIENCE
- Sunitinib administered prior to radiotherapy in patients with non-resectable glioblastoma: results of a Phase II study
- (2014) Carmen Balaña et al. Targeted Oncology
- Clinical significance of epigenetic silencing and re-expression of O6-methylguanine-DNA methyltransferase using epigenetic agents in laryngeal carcinoma
- (2014) JING YANG et al. Oncology Letters
- ABC transporters in CSCs membranes as a novel target for treating tumor relapse
- (2014) Laura Zinzi et al. Frontiers in Pharmacology
- Histone Acetyltransferase PCAF Is Required for Hedgehog-Gli-Dependent Transcription and Cancer Cell Proliferation
- (2013) M. Malatesta et al. CANCER RESEARCH
- Phase II Study of Bevacizumab in Combination with Sorafenib in Recurrent Glioblastoma (N0776): A North Central Cancer Treatment Group Trial
- (2013) E. Galanis et al. CLINICAL CANCER RESEARCH
- Phase III Randomized Trial Comparing the Efficacy of Cediranib As Monotherapy, and in Combination With Lomustine, Versus Lomustine Alone in Patients With Recurrent Glioblastoma
- (2013) Tracy T. Batchelor et al. JOURNAL OF CLINICAL ONCOLOGY
- Adenovirus-mediated gene therapy with sitimagene ceradenovec followed by intravenous ganciclovir for patients with operable high-grade glioma (ASPECT): a randomised, open-label, phase 3 trial
- (2013) Manfred Westphal et al. LANCET ONCOLOGY
- Erratum: Corrigendum: Comprehensive genomic characterization defines human glioblastoma genes and core pathways
- (2013) The Cancer Genome Atlas Research Network NATURE
- MicroRNAs and other non-coding RNAs as targets for anticancer drug development
- (2013) Hui Ling et al. NATURE REVIEWS DRUG DISCOVERY
- Transcriptional regulation of human DNA repair genes following genotoxic stress: trigger mechanisms, inducible responses and genotoxic adaptation
- (2013) M. Christmann et al. NUCLEIC ACIDS RESEARCH
- Survival and Death Strategies in Glioma Cells: Autophagy, Senescence and Apoptosis Triggered by a Single Type of Temozolomide-Induced DNA Damage
- (2013) Anna V. Knizhnik et al. PLoS One
- Improved tumor oxygenation and survival in glioblastoma patients who show increased blood perfusion after cediranib and chemoradiation
- (2013) T. T. Batchelor et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Personalized treatment strategies in glioblastoma: MGMT promoter methylation status
- (2013) Niklas Thon et al. OncoTargets and Therapy
- Erlotinib in Glioblastoma - Lost in Translation?
- (2012) Georg Karpel-Massler et al. Anti-Cancer Agents in Medicinal Chemistry
- Temozolomide-related idiosyncratic and other uncommon toxicities
- (2012) Sanjay Dixit et al. ANTI-CANCER DRUGS
- Hypoxia-Induced Autophagy Promotes Tumor Cell Survival and Adaptation to Antiangiogenic Treatment in Glioblastoma
- (2012) Y.-L. Hu et al. CANCER RESEARCH
- Image-Guided Prostate Biopsy Using Magnetic Resonance Imaging–Derived Targets: A Systematic Review
- (2012) Caroline M. Moore et al. EUROPEAN UROLOGY
- O6-Methylguanine DNA lesions induce an intra-S-phase arrest from which cells exit into apoptosis governed by early and late multi-pathway signaling network activation
- (2012) Ericka M. Noonan et al. Integrative Biology
- RTOG 0211: A Phase 1/2 Study of Radiation Therapy With Concurrent Gefitinib for Newly Diagnosed Glioblastoma Patients
- (2012) Arnab Chakravarti et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Continuous daily sunitinib for recurrent glioblastoma
- (2012) Teri Nguyen Kreisl et al. JOURNAL OF NEURO-ONCOLOGY
- A prospective phase II single-institution trial of sunitinib for recurrent malignant glioma
- (2012) Edward Pan et al. JOURNAL OF NEURO-ONCOLOGY
- Design and Selection of Toca 511 for Clinical Use: Modified Retroviral Replicating Vector With Improved Stability and Gene Expression
- (2012) Omar D Perez et al. MOLECULAR THERAPY
- A brain tumor molecular imaging strategy using a new triple-modality MRI-photoacoustic-Raman nanoparticle
- (2012) Moritz F Kircher et al. NATURE MEDICINE
- Tumor Immunotherapy Directed at PD-1
- (2012) Antoni Ribas NEW ENGLAND JOURNAL OF MEDICINE
- Prognostic Value of Three Different Methods of MGMT Promoter Methylation Analysis in a Prospective Trial on Newly Diagnosed Glioblastoma
- (2012) Arne Christians et al. PLoS One
- Image-guided Biopsy: What the Interventional Radiologist Needs to Know about PET/CT
- (2012) Katsuhiro Kobayashi et al. RADIOGRAPHICS
- Transforming Fusions of FGFR and TACC Genes in Human Glioblastoma
- (2012) D. Singh et al. SCIENCE
- Nuclear PARP-1 protein overexpression is associated with poor overall survival in early breast cancer
- (2011) F. Rojo et al. ANNALS OF ONCOLOGY
- Phase II trial of temsirolimus in children with high-grade glioma, neuroblastoma and rhabdomyosarcoma
- (2011) Birgit Geoerger et al. EUROPEAN JOURNAL OF CANCER
- Promoter methylation and expression of MGMT and the DNA mismatch repair genes MLH1, MSH2, MSH6 and PMS2 in paired primary and recurrent glioblastomas
- (2011) Jörg Felsberg et al. INTERNATIONAL JOURNAL OF CANCER
- An extent of resection threshold for newly diagnosed glioblastomas
- (2011) Nader Sanai et al. JOURNAL OF NEUROSURGERY
- Glioblastoma therapy in the elderly and the importance of the extent of resection regardless of age
- (2011) Ági Oszvald et al. JOURNAL OF NEUROSURGERY
- Immunological Effects of Low-dose Cyclophosphamide in Cancer Patients Treated With Oncolytic Adenovirus
- (2011) Vincenzo Cerullo et al. MOLECULAR THERAPY
- Targeted delivery of liposomal nanocontainers to the peritumoral zone of glioma by means of monoclonal antibodies against GFAP and the extracellular loop of Cx43
- (2011) Vladimir P. Chekhonin et al. Nanomedicine-Nanotechnology Biology and Medicine
- Fluorescent peptides highlight peripheral nerves during surgery in mice
- (2011) Michael A Whitney et al. NATURE BIOTECHNOLOGY
- Combined Use of Anticancer Drugs and an Inhibitor of Multiple Drug Resistance-Associated Protein-1 Increases Sensitivity and Decreases Survival of Glioblastoma Multiforme Cells In Vitro
- (2011) Lilia Peigñan et al. NEUROCHEMICAL RESEARCH
- Redirecting T-cell specificity by introducing a tumor-specific chimeric antigen receptor
- (2010) B. Jena et al. BLOOD
- Concurrent radiotherapy and temozolomide followed by temozolomide and sorafenib in the first-line treatment of patients with glioblastoma multiforme
- (2010) John D. Hainsworth et al. CANCER
- Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1
- (2010) Roel G.W. Verhaak et al. CANCER CELL
- Global Histone Modification Patterns as Prognostic Markers to Classify Glioma Patients
- (2010) B.-l. Liu et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Phase II Evaluation of Gefitinib in Patients With Newly Diagnosed Grade 4 Astrocytoma: Mayo/North Central Cancer Treatment Group Study N0074
- (2010) Joon H. Uhm et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Immunologic Escape After Prolonged Progression-Free Survival With Epidermal Growth Factor Receptor Variant III Peptide Vaccination in Patients With Newly Diagnosed Glioblastoma
- (2010) John H. Sampson et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Study of Cediranib, an Oral Pan–Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor, in Patients With Recurrent Glioblastoma
- (2010) Tracy T. Batchelor et al. JOURNAL OF CLINICAL ONCOLOGY
- Effect of CYP3A-inducing anti-epileptics on sorafenib exposure: results of a phase II study of sorafenib plus daily temozolomide in adults with recurrent glioblastoma
- (2010) David A. Reardon et al. JOURNAL OF NEURO-ONCOLOGY
- Effects of hypoxia on expression of a panel of stem cell and chemoresistance markers in glioblastoma-derived spheroids
- (2010) Jesper Kolenda et al. JOURNAL OF NEURO-ONCOLOGY
- BMI1 Confers Radioresistance to Normal and Cancerous Neural Stem Cells through Recruitment of the DNA Damage Response Machinery
- (2010) S. Facchino et al. JOURNAL OF NEUROSCIENCE
- Autophagy: cellular and molecular mechanisms
- (2010) Danielle Glick et al. JOURNAL OF PATHOLOGY
- Potentiating Cancer Immunotherapy Using an Oncolytic Virus
- (2010) Byram W Bridle et al. MOLECULAR THERAPY
- Evaluation of Intraoperative Brain Shift Using an Ultrasound-Linked Navigation System for Brain Tumor Surgery
- (2010) Shiro OHUE et al. NEUROLOGIA MEDICO-CHIRURGICA
- First-line treatment of malignant glioma with carmustine implants followed by concomitant radiochemotherapy: a multicenter experience
- (2010) Hans Christoph Bock et al. NEUROSURGICAL REVIEW
- Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
- (2010) Philip W. Kantoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- MEK–ERK-dependent multiple caspase activation by mitochondrial proapoptotic Bcl-2 family proteins is essential for heavy ion irradiation-induced glioma cell death
- (2010) A Tomiyama et al. Cell Death & Disease
- Convection-enhanced delivery of nanocarriers for the treatment of brain tumors
- (2009) Emilie Allard et al. BIOMATERIALS
- EGFRvIII-Targeted Vaccination Therapy of Malignant Glioma
- (2009) Bryan D. Choi et al. BRAIN PATHOLOGY
- Multicentre phase II studies evaluating imatinib plus hydroxyurea in patients with progressive glioblastoma
- (2009) D A Reardon et al. BRITISH JOURNAL OF CANCER
- Tobacco Smoke Induces Polycomb-Mediated Repression of Dickkopf-1 in Lung Cancer Cells
- (2009) M. Hussain et al. CANCER RESEARCH
- Phase II Study of Neoadjuvant Imatinib in Glioblastoma: Evaluation of Clinical and Molecular Effects of the Treatment
- (2009) E. Razis et al. CLINICAL CANCER RESEARCH
- CD133+ Glioblastoma Stem-like Cells are Radiosensitive with a Defective DNA Damage Response Compared with Established Cell Lines
- (2009) A. M. McCord et al. CLINICAL CANCER RESEARCH
- MSH6 Mutations Arise in Glioblastomas during Temozolomide Therapy and Mediate Temozolomide Resistance
- (2009) S. Yip et al. CLINICAL CANCER RESEARCH
- Hypoxia and Radiation Therapy: Past History, Ongoing Research, and Future Promise
- (2009) Sara Rockwell et al. CURRENT MOLECULAR MEDICINE
- Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma
- (2009) Henry S. Friedman et al. JOURNAL OF CLINICAL ONCOLOGY
- Novel biodegradable lipid nano complex for siRNA delivery significantly improving the chemosensitivity of human colon cancer stem cells to paclitaxel
- (2009) Changxing Liu et al. JOURNAL OF CONTROLLED RELEASE
- Phase 2 trial of erlotinib plus sirolimus in adults with recurrent glioblastoma
- (2009) David A. Reardon et al. JOURNAL OF NEURO-ONCOLOGY
- Poor drug distribution as a possible explanation for the results of the PRECISE trial
- (2009) John H. Sampson et al. JOURNAL OF NEUROSURGERY
- Effective sensitization of temozolomide by ABT-888 is lost with development of temozolomide resistance in glioblastoma xenograft lines
- (2009) M. J. Clarke et al. MOLECULAR CANCER THERAPEUTICS
- EXTENT OF RESECTION AND SURVIVAL IN GLIOBLASTOMA MULTIFORME
- (2009) et al. NEUROSURGERY
- O6-Methylguanine-DNA methyltransferase inactivation and chemotherapy
- (2008) B. Verbeek et al. BRITISH MEDICAL BULLETIN
- Phase II Study of Imatinib in Patients With Recurrent Gliomas of Various Histologies: A European Organisation for Research and Treatment of Cancer Brain Tumor Group Study
- (2008) Eric Raymond et al. JOURNAL OF CLINICAL ONCOLOGY
- A pilot study of everolimus and gefitinib in the treatment of recurrent glioblastoma (GBM)
- (2008) Teri N. Kreisl et al. JOURNAL OF NEURO-ONCOLOGY
- GLIOMA EXTENT OF RESECTION AND ITS IMPACT ON PATIENT OUTCOME
- (2008) Nader Sanai et al. NEUROSURGERY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search